|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 262, Issue 6 E956-E962, Copyright © 1992 by American Physiological Society
ARTICLES |
A. Flyvbjerg, J. Frystyk, R. Osterby and H. Orskov
Institute of Experimental Clinical Research, University of Aarhus, Aarhus Kommunehospital, Denmark.
Insulin-like growth factor I (IGF-I) has been proposed as a renotropic factor in initial diabetic kidney growth. To examine the effects of an isolated growth hormone (GH) and IGF-I deficiency on diabetic renal hypertrophy, dwarf rats were made diabetic and studied over a period of 7 days. Diabetic dwarf rats treated with human GH (hGH) or insulin and diabetic rats with intact pituitary were used as controls. In diabetic control animals kidney weight had increased by day 2 (P less than 0.01), and the increase amounted to 27% after 7 days, whereas untreated diabetic dwarf rats had a slower and lesser degree of kidney weight increase, reaching significance on day 7 only, amounting to 8%. hGH administration in diabetic dwarf rats increased the kidney weight on day 7 when compared with untreated diabetic dwarf rats (P less than 0.05) and was 19% over that of insulin-treated diabetic dwarf rats. The glomerular volume had increased by 43% in untreated diabetic control rats at day 7, compared with a 29% increase in untreated diabetic dwarf rats (P less than 0.05). hGH administration in diabetic dwarf rats increased the glomerular volume by 46%, comparable to the increase seen in diabetic control animals. Kidney IGF-I was increased on day 2 by 51 and 46% in saline- and hGH-injected diabetic dwarf rats, respectively, but a significantly higher increase in kidney IGF-I amounting to 96% was seen in diabetic control rats.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
B. P. S. Kang, A. Urbonas, A. Baddoo, S. Baskin, A. Malhotra, and L. G. Meggs IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose Am J Physiol Renal Physiol, November 1, 2003; 285(5): F1013 - F1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Flyvbjerg, B. F. Schrijvers, A. S. De Vriese, R. G. Tilton, and R. Rasch Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E362 - E366. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C.P. Thirone, J. A. Scarlett, A. L. Gasparetti, E. P. Araujo, M. H.L. Lima, C. R.O. Carvalho, L. A. Velloso, and M. J.A. Saad Modulation of Growth Hormone Signal Transduction in Kidneys of Streptozotocin-Induced Diabetic Animals: Effect of a Growth Hormone Receptor Antagonist Diabetes, July 1, 2002; 51(7): 2270 - 2281. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Bach, R. Dean, S. Youssef, and M. E. Cooper Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy Nephrol. Dial. Transplant., March 1, 2000; 15(3): 347 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. SEGEV, D. LANDAU, R. RASCH, A. FLYVBJERG, and M. PHILLIP Growth Hormone Receptor Antagonism Prevents Early Renal in Nonobese Diabetic Mice J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2374 - 2381. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |